Clinical Trial Update: Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating 18F-fluorodeoxyglucose imaging (FluGlucoScan) to guide three-dimensional conformal radiation therapy with breath-held CT and PET in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• FluGlucoScan (fluorodeoxyglucose)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Lung Neoplasms | Phase 2 | Status: COMPLETED